BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Agilent Technologies, Inc. (Santa Clara, California) (A) Expands HaloPlex Target Enrichment for Ion Torrent Next-Generation Sequencers


6/4/2012 12:42:26 PM

SANTA CLARA, Calif., June 4, 2012 – Agilent Technologies Inc. (NYSE: A) today announced the expansion of the HaloPlex target enrichment system, which will now be available on Ion Torrent’s Personal Genome Machine, a benchtop sequencing solution.

The HaloPlex system features a unique paired-end design, which positions reads at both target ends using a single-end sequencing run. By taking advantage of the extra coverage that the paired-end design provides, researchers will be able to save sequencing costs and time.

“The HaloPlex technology makes it possible for us to capture specific sets of genes in a single reaction,” said Peter Ray, head of molecular genetics at The Hospital for Sick Children in Toronto, Canada. “So far we have gotten great coverage of the mutations we were looking for. By combining HaloPlex with Ion Torrent we are able to generate sequencing data for our targets in a single day.”

HaloPlex continues to break barriers common to other target enrichment technologies and can now enable larger capture sizes during desktop sequencing – up to 5Mb or approximately 2,000 genes on a MiSeq personal sequencer. HaloPlex offers greater efficiency and improved performance and, with the update released today, it allows researchers to process up to 250,000 amplicons in the same tube.

“HaloPlex is helping to transform target enrichment, especially for desktop sequencers,” said Olle Ericsson, director of marketing, DNA sequencing at Agilent. “We are overcoming previous barriers with the fastest, most flexible and most innovative target enrichment platform on the market.”

The Haloplex system’s fast-scaling target enrichment technology demonstrates Agilent’s ongoing commitment to enabling a better research workflow regardless of the sequencer platform being used.

HaloPlex is a flexible and customizable product that enables users to create designs in less than 10 minutes to enrich thousands of genomic targets, using the no-charge Web Design Wizard.

Agilent acquired Halo Genomics of Uppsala, Sweden, and the HaloPlex platform in December, 2011. HaloPlex technology complements the existing Agilent SureSelect target-enrichment system.

For more information, visit www.agilent.com/genomics/ngs.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,700 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->